Alphatec Holdings, Inc.
Alphatec Holdings, Inc. designs and develops medical technologies for spinal disorders treatment. It manufactures implants and instruments through third-party suppliers. The company offers various products, including imaging systems, alignment tools, and robotics-based intra-operative systems. Products also include spinal implants, fixation systems, and biologics such as bone grafts and tissue barriers. Sales are made through a network of independent agents and direct sales representatives. Founded in 1990, the company is headquartered in Carlsbad, California.
Overview
Strengths
- No significant strengths identified based on the analyzed metrics.
Weaknesses
- With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
- Price to book ratio (100.00) is significantly higher than the sector mean (13.90).
- Analysts expect revenues to decline in the coming year.
- The company has high debt. Net Debt to EBITDA Ratio (100.00) is higher than the sector mean.
- The company have lower returns than the sector in which it operates. ROIC (0.00%) is significantly lower than the sector mean (2.97%).
- EV/EBIT (100.00) is significantly higher than the sector mean.
- EBITDA Margin (0.00%) appears relatively low.
Key Financial Data
| Indicator | Value |
|---|
| PER | 100.0 |
| EV/EBITDA | 100.0 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | -% |
| Net Debt/EBITDA | 100.0 |